Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Health Care · ·
$6.21
▼ $0.04 (-0.6%)
Market data updated: 09/15 05:31 PM
Fundamentals updated: 09/15/2026
News analyzed: 09/15/2026
Market Cap
$77.82M
Day Range
$6.16 - $6.32
52-Week Range
$3.90 - $11.71
Beta
—
Next Earnings
02.11.2026
LFVN is a stock from the Healthcare sector — Pharmaceuticals, biotech, medical devices, and health insurance — less sensitive to economic cycles, but exposed to regulation and FDA approvals.
-41.8% (1Y)
Strengths: 6/28 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
DCF Fair Value
Estimated fair value: $7.10 vs. price $6.21 (+14.3%)
Fair Value
Biggest negative driver
Operating margin stability
Operating margin is eroding over time
Quality
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
45
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
Not enough data yet to generate this synthesis.
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
26
Quality
42
Value
62
Momentum
37
Risk
40
Sentiment
44
Fundamental
59
Institutional
71
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Everyone's writing about Lifevantage Corporation. News trend score: 44. Reason: 5 of the last 20 articles are negative, versus 4 positive.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
10
🎯 Conviction (vs. Emotion)
35
Psychology
30
Fundamentals
59
Technical
37
Valuation
62
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Extreme momentum, price far above its moving average, and a large premium over fair value.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
+3%
Market Narrative
28
Fundamental Reality
35
Narrative Gap
-7
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Charles Mackay — 94/100
🔴 Weakest match
Morgan Housel — 0/100
🗣️ Why do they disagree?
Based on Charles Mackay’s documented principles, the model estimates LFVN shows no crowd mania, and Howard Marks’ cycle‑based criteria likewise rate it early‑to‑mid cycle (scores 81 and 73), leading to relatively favorable views. By contrast, Benjamin Graham’s value tests (score 52) and Edgar Lawrence Smith’s long‑term holding standards (score 45) find the stock only marginally meets intrinsic‑value thresholds, while Walter Bagehot (42) and Gerald Loeb (34) flag liquidity and risk concerns. Growth‑oriented frameworks such as Peter Lynch (8) and Philip Fisher (7) assign very low scores because LFVN fails their quality‑and‑reasonable‑price bars. Even the efficient‑market perspective of Malkiel & Bogle (35) judges the evidence for out‑performance as weak. Thus, cycle‑ and sentiment‑focused methodologies are comparatively optimistic, whereas value, growth, and risk‑averse approaches are largely skeptical.
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 94
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 77
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 73
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 66
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 53
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 45
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 42
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 41
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 40
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 37
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 37
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 36
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🔴 34
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 8
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 7
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 0
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Based on the last 277 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (2 bullish · 6 bearish · 3 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
A pattern consistent with an early/mid distribution phase — a trading range after an advance with declining volume.
Medium confidence
$5.82
Range Bottom
$6.97
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
77.6%
Operating Margin
3.3%
Net Margin
2.8%
EBITDA Margin
4.9%
ROE
15.1%
ROA
8.2%
ROIC
—
EPS
$0.40
Cash
$14.92M
Total Debt
—
Current Ratio
1.89
Debt/Equity
—
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 1.9.2026 | $0.050 |
| 1.6.2026 | $0.050 |
| 31.5.2026 | $0.050 |
| 2.3.2026 | $0.045 |
| 1.3.2026 | $0.045 |
| 1.12.2025 | $0.045 |
| 30.11.2025 | $0.045 |
| 8.9.2025 | $0.045 |
| 7.9.2025 | $0.045 |
| 30.5.2025 | $0.045 |
| 29.5.2025 | $0.045 |
| 3.3.2025 | $0.040 |
How is Fair Value calculated? →
Current Price
$6.21
Estimated Fair Value (DCF)
$7.10
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+14.3%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
-4.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -4.0% | $6.40M | $5.87M |
| 2 | -2.4% | $6.25M | $5.26M |
| 3 | -0.8% | $6.20M | $4.79M |
| 4 | 0.9% | $6.25M | $4.43M |
| 5 | 2.5% | $6.41M | $4.16M |
Base FCF (last actual year)
$6.67M
Terminal Value
$101.04M
Present Value of Terminal Value
$65.67M
Enterprise Value
$90.18M
Net Debt
$0
Equity Value
$90.18M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$2.64
Tangible Book Value per Share (Tangible NAV)
$2.37
Sentiment based on basic keywords (not AI) — 4 positive, 11 neutral, 5 negative out of the last 20 articles.
Benzinga · 15.9.2026
Yahoo · 31.8.2026
Motley Fool · 31.8.2026
Yahoo · 28.8.2026
Moby · 28.8.2026
Benzinga · 28.8.2026
Yahoo · 28.8.2026
GuruFocus.com · 28.8.2026
Yahoo · 27.8.2026
MarketBeat · 27.8.2026
MT Newswires · 27.8.2026
Associated Press · 27.8.2026
Yahoo · 27.8.2026
GlobeNewswire · 27.8.2026
SeekingAlpha · 27.8.2026
Benzinga · 27.8.2026
Benzinga · 27.8.2026
Benzinga · 27.8.2026
Benzinga · 27.8.2026
GlobeNewswire · 21.8.2026
Lifevantage Corporation (LFVN) currently has a StockIQ AI score of 45/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
LFVN currently scores 45/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, LFVN's estimated fair value is $7.10, which is 14.3% above the current price of $6.21. This is one valuation model among several signals in the fair-value category, not a price target.
LFVN's technical score is 37/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Estimated fair value: $7.10 vs. price $6.21 (+14.3%); Current ratio: 1.89; Price is above the 200-day average.
Based on the real signals StockIQ computed: Operating margin is eroding over time; ATR: 5.6% of price; Calmar: -0.02 (3y annualized return -1.6% / max drawdown 84.3%).
Yes — LFVN has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 5 purchases and 2 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Moorehead Terrence | Grant/Award from Employer | 6.8.2026 | 540,123 | +540,123 | — |
| Moorehead Terrence | Grant/Award from Employer | 6.8.2026 | 308,642 | +308,642 | — |
| Moorehead Terrence | Grant/Award from Employer | 6.8.2026 | 308,642 | +308,642 | — |
| Moorehead Terrence | Grant/Award from Employer | 6.8.2026 | 540,123 | +540,123 | — |
| Aure Carl | Tax Withholding in Shares | 1.7.2026 | 1,361 | -1,361 | $6.25 |
| Neufeld Alissa | Tax Withholding in Shares | 1.7.2026 | 1,342 | -1,342 | $6.25 |
| Cunningham Kristen | Tax Withholding in Shares | 1.7.2026 | 1,717 | -1,717 | $6.25 |
| Neufeld Alissa | Tax Withholding in Shares | 1.7.2026 | 112,744 | -1,342 | $6.25 |
| Aure Carl | Tax Withholding in Shares | 1.7.2026 | 155,554 | -1,361 | $6.25 |
| Cunningham Kristen | Tax Withholding in Shares | 1.7.2026 | 131,417 | -1,717 | $6.25 |
| Lewis Darwin | Open Market Purchase | 15.6.2026 | 705 | +705 | $8.60 |
| BEINDORFF MICHAEL A | Open Market Sale | 3.6.2026 | 10,000 | -10,000 | $8.55 |
| BEINDORFF MICHAEL A | Open Market Sale | 3.6.2026 | 41,625 | -10,000 | $8.55 |
| Aure Carl | Tax Withholding in Shares | 1.4.2026 | 1,527 | -1,527 | $4.20 |
| Fife Steven R | Tax Withholding in Shares | 1.4.2026 | 8,180 | -8,180 | $4.20 |
| Neufeld Alissa | Tax Withholding in Shares | 1.4.2026 | 1,446 | -1,446 | $4.20 |
| Cunningham Kristen | Tax Withholding in Shares | 1.4.2026 | 1,928 | -1,928 | $4.20 |
| Fife Steven R | Tax Withholding in Shares | 1.4.2026 | 735,471 | -8,180 | $4.20 |
| Neufeld Alissa | Tax Withholding in Shares | 1.4.2026 | 114,086 | -1,446 | $4.20 |
| Aure Carl | Tax Withholding in Shares | 1.4.2026 | 156,915 | -1,527 | $4.20 |
| Cunningham Kristen | Tax Withholding in Shares | 1.4.2026 | 133,134 | -1,928 | $4.20 |
| Lewis Darwin | Open Market Purchase | 16.3.2026 | 1,055 | +1,055 | $5.23 |
| Lewis Darwin | Open Market Purchase | 16.3.2026 | 136,563 | +1,055 | $5.23 |
| Dayton Judd | Open Market Purchase | 2.3.2026 | 10,500 | +10,500 | $4.53 |
| Dayton Judd | Open Market Purchase | 2.3.2026 | 80,359 | +10,500 | $4.53 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
1,221,521 shares short as of 2026-08-31 · vs. 1,263,292 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
41.3% of trading volume this week was short selling, vs. 44.1% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology